Superantigenic activity produced by group a streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock snydrome patients

Advances in Experimental Medicine and Biology

Volumn 418, Issue , 1997, Pages 563-566

  Norrby Teglund, Anna ^a   Low, Donald E ^b   McGeer, Allison ^b   Kotb, Malak ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; LYMPHOTOXIN; NEUTRALIZING ANTIBODY; SUPERANTIGEN;

ANTIBODY PRODUCTION; BACTERIUM ISOLATION; CLINICAL ARTICLE; CONFERENCE PAPER; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MITOGENICITY; PLASMA; PRIORITY JOURNAL; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME;

ANTIBODIES, BACTERIAL; BACTERIAL PROTEINS; EXOTOXINS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INTERFERON TYPE II; LYMPHOTOXIN-ALPHA; MEMBRANE PROTEINS; NEUTRALIZATION TESTS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; SUPERANTIGENS;

EID: 0030851679     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4899-1825-3_130     Document Type: Article

References (13)

1. Cone, LA, Woodard, DR, Schlievert, PM, and Tomory, GS. 1987. Clinical and bacteriological observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med., 3:146-149.
2. Stevens, DL, Tanner, MH, Winship, J, Swarts, R. Ries, KM, Schlievert, PM, and Kaplan, E. 1989. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N. Engl. J. Med., 321:1-7.
3. The Working Group on Severe Streptococcal Infections. 1993. Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. JAMA, 269:390-1.
4. Kotb, M. 1995. Bacterial exotoxins as superantigens. Clin. Microbiol. Rev., 8:411-426.
5. Schlievert, PM. 1993. Role of superantigens in human diseases. J.Infect. Dis., 167:997-1002.
6. Tomai, M, Schlievert, PM, and Kotb, M. 1992. Distinct T Cell receptor Vβ Gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and M protein. Infect. Immun., 60:701-5.
7. Watanabe-Ohnishi, R, Low, DE, McGeer, A, Stevens, DL, Schlievert, PM, Newton, D, Schwartz, B, Kreiswirth, B, project, Oss, and Kotb, M. 1995. Selective Depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J. Infect. Dis., 171:74-84.
8. Michie, c, Scott, A, Cheesbrough, J, Beverley, P, and Pasvol, G. 1994. Streptococcal toxic shock-like syndrome: evidence of superantigen activity and its effect on T lymphocyte subsets in vivo. Clin. Exp. Immunol., 98:140-144.
9. Takei, S, Arora, YK, and Walker, SM. 1993. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens. J. Clin. Invest., 91:602-7.
10. Skansen-Saphir, U, Andersson, J, Bjork, L, and Andersson, U. 1994. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG. Eur. J. Immunol., 24:916-22.
11. Norrby-Teglund, A. Kaul, R, Low, DE, McGeer, A, Andersson, JP, Andersson, UG, and Kotb, M. 1996. Plasma from patients with severe invasive group A streptococcal infections treated with polyspecific IgG (IVIG) inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J. Immunol., 156:3057-3064.
12. Norrby-Teglund, A, Kaul, R, Low, DE, McGeer, A, Andersson, JP, Andersson, UG, and Kotb, M. 1996. Evidence for the presence of streptococcal superantigen neutralizing antibidies in normal polyspecific Ig G (IVIG). Infect. Immun., (in press).
13. Kaul, R, McGeer, A, group, Canadian Infectious Disease Society, Norrby-Teglund, A, Kotb, M, and Low, DE. 1995. Intravenous immunoglobulin (IVIG) therapy in streptococcal toxic shock syndrome (STSS): results of a matched case-control study. 35th Interscience conference on antimicrobial agents and chemotherapy, LM68 (Abstr.).